AstraZeneca Vaccine Unfairly Under Fire Over Clot Risk?

(MedPage Today) -- Thromboembolic and bleeding risk has been cited by a number of countries in halting use of AstraZeneca's COVID-19 vaccine, but the company and health agencies argued against a causal link.
Denmark and Norway were first to stop...